AMERICAN CENTURY COMPANIES INC - TURNING POINT THERAPEUTICS I ownership

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q4 2021$26,109,000
-28.2%
547,354
-0.0%
0.02%
-32.0%
Q3 2021$36,362,000
-2.3%
547,370
+14.7%
0.02%0.0%
Q2 2021$37,226,000
+8.5%
477,133
+31.5%
0.02%0.0%
Q1 2021$34,318,000
-29.1%
362,806
-8.6%
0.02%
-34.2%
Q4 2020$48,374,000
+25.4%
396,999
-10.1%
0.04%
+11.8%
Q3 2020$38,585,000
+20.0%
441,675
-11.3%
0.03%
+13.3%
Q2 2020$32,147,000
+59.5%
497,704
+10.3%
0.03%
+25.0%
Q1 2020$20,155,000
-15.0%
451,300
+18.6%
0.02%
+4.3%
Q4 2019$23,711,000
+101.1%
380,660
+21.4%
0.02%
+91.7%
Q3 2019$11,791,000313,5810.01%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,750,000$260,122,0005.80%
Burrage Capital Management LLC 72,164$6,826,0005.53%
Consonance Capital Management LP 450,396$42,603,0004.54%
MPM BioImpact LLC 269,186$25,462,0003.20%
Orbimed Advisors 2,361,327$223,358,0002.09%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 81,541$7,711,0002.04%
SECTORAL ASSET MANAGEMENT INC 257,879$24,393,0001.85%
Nicholas Investment Partners, LP 218,847$20,701,0001.44%
Logos Global Management LP 140,000$13,243,0001.29%
SILVERARC CAPITAL MANAGEMENT, LLC 16,741$1,584,0000.86%
View complete list of TURNING POINT THERAPEUTICS I shareholders